- Home
- INZY vs RENB Comparison
INZY vs RENB Comparison
Compare INZY & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- RENB
- Stock Information
- Founded
- INZY 2015
- RENB 2011
- Country
- INZY United States
- RENB United States
- Employees
- INZY N/A
- RENB N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- INZY Health Care
- RENB Health Care
- Exchange
- INZY Nasdaq
- RENB Nasdaq
- Market Cap
- INZY 64.9M
- RENB 61.0M
- IPO Year
- INZY 2020
- RENB N/A
- Fundamental
- Price
- INZY $1.15
- RENB $0.32
- Analyst Decision
- INZY Strong Buy
- RENB
- Analyst Count
- INZY 9
- RENB 0
- Target Price
- INZY $17.22
- RENB N/A
- AVG Volume (30 Days)
- INZY 1.1M
- RENB 692.5K
- Earning Date
- INZY 05-20-2025
- RENB 05-19-2025
- Dividend Yield
- INZY N/A
- RENB N/A
- EPS Growth
- INZY N/A
- RENB N/A
- EPS
- INZY N/A
- RENB N/A
- Revenue
- INZY N/A
- RENB N/A
- Revenue This Year
- INZY N/A
- RENB N/A
- Revenue Next Year
- INZY N/A
- RENB N/A
- P/E Ratio
- INZY N/A
- RENB N/A
- Revenue Growth
- INZY N/A
- RENB N/A
- 52 Week Low
- INZY $0.72
- RENB $0.29
- 52 Week High
- INZY $6.24
- RENB $2.34
- Technical
- Relative Strength Index (RSI)
- INZY 50.96
- RENB 37.38
- Support Level
- INZY $1.18
- RENB $0.29
- Resistance Level
- INZY $1.63
- RENB $0.35
- Average True Range (ATR)
- INZY 0.20
- RENB 0.05
- MACD
- INZY 0.02
- RENB 0.01
- Stochastic Oscillator
- INZY 23.66
- RENB 18.83
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.